SE465751B - Farmaceutiskt preparat innehaallande co-dergocrin och en kalciumantagonist - Google Patents

Farmaceutiskt preparat innehaallande co-dergocrin och en kalciumantagonist

Info

Publication number
SE465751B
SE465751B SE8402199A SE8402199A SE465751B SE 465751 B SE465751 B SE 465751B SE 8402199 A SE8402199 A SE 8402199A SE 8402199 A SE8402199 A SE 8402199A SE 465751 B SE465751 B SE 465751B
Authority
SE
Sweden
Prior art keywords
alkyl
mixture
dihydroergocornine
dihydroergocryptine
dihydroergocristine
Prior art date
Application number
SE8402199A
Other languages
English (en)
Swedish (sv)
Other versions
SE8402199D0 (sv
SE8402199L (sv
Inventor
D Welzel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8402199D0 publication Critical patent/SE8402199D0/xx
Publication of SE8402199L publication Critical patent/SE8402199L/xx
Publication of SE465751B publication Critical patent/SE465751B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE8402199A 1983-04-22 1984-04-19 Farmaceutiskt preparat innehaallande co-dergocrin och en kalciumantagonist SE465751B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3314607 1983-04-22

Publications (3)

Publication Number Publication Date
SE8402199D0 SE8402199D0 (sv) 1984-04-19
SE8402199L SE8402199L (sv) 1984-10-23
SE465751B true SE465751B (sv) 1991-10-28

Family

ID=6197070

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8402199A SE465751B (sv) 1983-04-22 1984-04-19 Farmaceutiskt preparat innehaallande co-dergocrin och en kalciumantagonist

Country Status (27)

Country Link
US (2) US4617306A (fa)
JP (1) JPS59205318A (fa)
AT (1) AT393625B (fa)
AU (1) AU571218B2 (fa)
BE (1) BE899434A (fa)
CA (1) CA1218932A (fa)
CH (1) CH658992A5 (fa)
CY (1) CY1499A (fa)
DD (1) DD217712A5 (fa)
DK (1) DK165965C (fa)
FR (1) FR2544614B1 (fa)
GB (1) GB2138678B (fa)
GR (1) GR81973B (fa)
HK (1) HK100289A (fa)
HU (1) HU192050B (fa)
IE (1) IE57468B1 (fa)
IL (1) IL71601A (fa)
IT (1) IT1199114B (fa)
LU (1) LU85331A1 (fa)
MY (1) MY100397A (fa)
NL (1) NL188891C (fa)
NZ (1) NZ207917A (fa)
PH (1) PH20922A (fa)
PT (1) PT78455B (fa)
SE (1) SE465751B (fa)
SG (1) SG53889G (fa)
ZA (1) ZA842993B (fa)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159604B1 (en) * 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
EP1970052A2 (en) * 1999-02-09 2008-09-17 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
US6209563B1 (en) 2000-01-07 2001-04-03 Saturn Electronics & Engineering, Inc. Solenoid control valve
US6321767B1 (en) 2000-01-10 2001-11-27 Saturn Electronics & Engineering, Inc. High flow solenoid control valve
US6581634B2 (en) 2000-01-10 2003-06-24 Saturn Electronics & Engineering, Inc. Solenoid control valve with particle gettering magnet
US20090166274A1 (en) * 2007-05-24 2009-07-02 Eaton Corporation Engine valve with a combined engine oil filter and valve actuator solenoid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5468M (fa) * 1966-06-24 1967-10-16
US3567828A (en) * 1967-08-17 1971-03-02 Sandoz Ltd Organic compounds
SE426782B (sv) * 1975-05-31 1983-02-14 Sandoz Ag Sett att framstella stabila losningar av hydrerade mjoldrygealkaloider, deras syntetiska derivat eller deras salter
JPS5487177A (en) * 1977-12-23 1979-07-11 Fujitsu Ltd Component positioning unit
WO1980001242A1 (fr) * 1978-12-21 1980-06-26 Sandoz Ag Preparations galeniques
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen
GB2063670A (en) * 1979-11-28 1981-06-10 Sandoz Products Ltd Ergots and their use in treating minimal brain dysfunction

Also Published As

Publication number Publication date
IE840977L (en) 1984-10-22
GB2138678A (en) 1984-10-31
DD217712A5 (de) 1985-01-23
SE8402199D0 (sv) 1984-04-19
HK100289A (en) 1989-12-29
AU571218B2 (en) 1988-04-14
DK201884D0 (da) 1984-04-18
DK201884A (da) 1984-10-23
GR81973B (fa) 1984-12-12
GB2138678B (en) 1986-11-05
PT78455A (en) 1984-05-01
CA1218932A (en) 1987-03-10
JPS59205318A (ja) 1984-11-20
IT1199114B (it) 1988-12-30
LU85331A1 (fr) 1984-11-28
FR2544614B1 (fr) 1987-08-21
PH20922A (en) 1987-06-05
PT78455B (en) 1986-05-27
IE57468B1 (en) 1993-01-27
NZ207917A (en) 1988-05-30
HU192050B (en) 1987-05-28
ZA842993B (en) 1985-11-27
NL188891C (nl) 1992-11-02
DK165965B (da) 1993-02-22
CY1499A (en) 1990-08-03
IL71601A (en) 1988-12-30
IT8448082A0 (it) 1984-04-20
ATA133784A (de) 1991-05-15
CH658992A5 (de) 1986-12-31
NL8401155A (nl) 1984-11-16
SG53889G (en) 1989-12-08
FR2544614A1 (fr) 1984-10-26
JPH0564124B2 (fa) 1993-09-14
US4797404A (en) 1989-01-10
SE8402199L (sv) 1984-10-23
AU2712084A (en) 1984-10-25
IT8448082A1 (it) 1985-10-20
IL71601A0 (en) 1984-07-31
HUT37889A (en) 1986-03-28
DK165965C (da) 1993-07-26
US4617306A (en) 1986-10-14
GB8410363D0 (en) 1984-05-31
BE899434A (fr) 1984-10-16
MY100397A (en) 1990-09-17
AT393625B (de) 1991-11-25

Similar Documents

Publication Publication Date Title
AU740486B2 (en) Pharmaceutical composition for oral administration of a N-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
FI83839B (fi) Foerfarande foer framstaellning av en dihydropyridin-a snabbt frigoerande fast dispersion.
HUP0203330A2 (hu) Benzamidszármazékot tartalmazó javított oldhatóságú és orális felszívódású gyógyszerkészítmények
HU199302B (en) Process for producing synergic pharmaceutical compositions having hypotensive activity
EP0344603A1 (en) Pharmaceutical composition of dihydropyridine compound
JPS6121550B2 (fa)
JP2002537258A5 (fa)
KR960006060B1 (ko) 비드 형태의 신규 제약 조성물 및 그의 제조 방법
DK146194B (da) Fremgangsmaade til fremstilling af et fast stof indeholdende et eller flere hydrogenerede meldroejealkaloider
KR20190107887A (ko) 아픽사반을 포함하는 가용화를 위한 약제학적 제제 및 이의 제조 방법
SE465751B (sv) Farmaceutiskt preparat innehaallande co-dergocrin och en kalciumantagonist
JPH04360833A (ja) １，４−ジヒドロピリジン誘導体を含有する製剤
JPH08325145A (ja) 安定なイソプロピルアンチピリン含有製剤
HRP980074A2 (en) Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
JPS62132826A (ja) 抗高血圧剤
JPH0361644B2 (fa)
WO1999018957A1 (en) Stable pharmaceutical composition containing amlodipine besylate and atenolol
HUT70173A (en) 3-benzoyl-3,7-diazabicyclo[3.3.1] nonane compounds and pharmaceutical compositions containing them
US3947590A (en) Compositions and methods of increasing renal blood flow with gamma-glutamyl amide of dopamine
WO1996025932A1 (en) Preventive/remedy for interstitial pneumonia, inflammatory intestinal diseases or vascular thickening containing quinolizinone compounds, salt thereof or hydrates therefor
JPH04235168A (ja) 強心薬
CS207455B2 (en) Method of preparation of the new therapeutic mixture
JPS63150224A (ja) 脳機能改善薬
JPH0881374A (ja) 皮膚そう痒症の予防または治療薬
MXPA99007507A (en) Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8402199-7

Effective date: 19941110

Format of ref document f/p: F